Celcuity (CELC) Stock Price
Celcuity Price
Celcuity (CELC) Stock | ISIN US15102K1007 | WKN A2JAAX. The current Celcuity stock price is 87.44 USD (2026). Revenue is 44.91 M USD. Net income is -164.18 M USD. The P/E ratio is -21.01. Market capitalization is 3.45 B USD. Celcuity operates in the Health sector.
Celcuity stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Celcuity over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Celcuity stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Celcuity's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Celcuity Price |
|---|
Celcuity Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Celcuity Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Celcuity generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Celcuity retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Celcuity's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Celcuity has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Celcuity's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Celcuity stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Celcuity Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Celcuity business model & stock analysis
Celcuity SWOT Analysis
Strengths
Celcuity Inc possesses several strengths that contribute to its competitive advantage in the market:
- Cutting-edge technology and innovative solutions
- Strong intellectual property portfolio
- Highly skilled and experienced research and development team
- Strong relationships with key industry partners
- Solid financial position and strong revenue growth
Weaknesses
Despite its strengths, Celcuity Inc also has certain weaknesses that can impact its performance:
- Relatively small size compared to established competitors
- Limited brand recognition in the market
- Dependency on a few key customers
- Limited marketing and distribution capabilities
- Risk of potential regulatory challenges
Opportunities
Celcuity Inc can capitalize on the following opportunities to further expand and develop its business:
- Growing demand for personalized medicine and targeted therapies
- Increase in healthcare spending and focus on precision oncology
- Expansion into new geographic markets
- Potential collaborations and partnerships with pharmaceutical companies
- Advancements in technology and data analytics
Threats
Celcuity Inc faces the following threats that may hinder its growth and success:
- Intense competition from established players in the industry
- Fast-paced technological advancements and potential disruption
- Stringent regulations and compliance requirements
- Economic fluctuations and market uncertainties
- Potential intellectual property disputes and legal challenges
Celcuity Eulerpool Fair Value
Celcuity historical P/E ratio, EBIT multiple, and P/S ratio
Celcuity annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Celcuity shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Celcuity Earnings Estimates
Celcuity Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/18/2026 | -1.07USD | 0USD | 2026 Q1 |
| 5/14/2026 | -1.07USD | 0USD | 2026 Q1 |
| 5/12/2026 | -1.07USD | 0USD | 2026 Q1 |
| 3/25/2026 | -1.06USD | 0USD | 2025 Q4 |
| 3/19/2026 | -1.06USD | 0USD | 2025 Q4 |
| 11/14/2024 | -0.67USD | 0USD | 2024 Q3 |
| 11/11/2024 | -0.67USD | 0USD | 2024 Q3 |
| 5/13/2024 | -0.81USD | 0USD | 2024 Q1 |
| 3/21/2024 | -0.82USD | 0USD | 2023 Q4 |
| 11/8/2023 | -0.41USD | 0USD | 2023 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Celcuity stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Celcuity shareholder structure
| % | Name |
|---|---|
20.06568% | |
8.01077% | |
7.91136% | |
7.88633% | |
7.37796% | |
5.76979% | |
5.68708% | |
4.58374% | |
4.34481% | |
4.15136% |
Celcuity Executives and Management Board
Mr. Brian Sullivan
(63)Chairman of the Board, Chief Executive Officer, Co-Founder · since 2012
Dr. Lance Laing
(63)Co-Founder, Chief Science Officer, Vice President, Secretary, Director · since 2012
Ms. Vicky Hahne
(58)Chief Financial Officer
Dr. Richard Buller
(75)Independent Director
Mr. David Dalvey
(66)Independent Director
Celcuity Supply Chain
Frequently asked questions about Celcuity
Celcuity Inc, a targeted diagnostics company, operates on a unique business model focusing on developing and commercializing novel companion diagnostic tests. By analyzing a patient's living cancer cells used in diagnostic testing, Celcuity gathers crucial data to identify abnormal signaling pathways that can guide physicians in selecting the most effective treatment. Leveraging its proprietary CELsignia platform, Celcuity aims to improve patient outcomes by enabling the identification of patients who are likely to respond favorably to specific targeted therapies. Through its innovative approach, Celcuity strives to revolutionize personalized medicine in the field of cancer diagnostics.
Celcuity stock
Celcuity Peer Group
Celcuity Ticker
Celcuity FIGI
All fundamentals and in-depth analysis of Celcuity
Our stock analysis for Celcuity Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Celcuity Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.